CID 11676932

Irbesartan metabolite 3

Structural Information

Molecular Formula
C25H26N6O3
SMILES
C1CCC2(C1)C(=O)N(C(=N2)CCCC(=O)O)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C25H26N6O3/c32-22(33)9-5-8-21-26-25(14-3-4-15-25)24(34)31(21)16-17-10-12-18(13-11-17)19-6-1-2-7-20(19)23-27-29-30-28-23/h1-2,6-7,10-13H,3-5,8-9,14-16H2,(H,32,33)(H,27,28,29,30)
InChIKey
SQPSUXCOWHFKKF-UHFFFAOYSA-N
Compound name
4-[4-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-2-yl]butanoic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

458.20663 Da
Monoisotopic Mass

2.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 459.21391 205.8
[M+Na]+ 481.19585 211.3
[M-H]- 457.19935 212.0
[M+NH4]+ 476.24045 211.4
[M+K]+ 497.16979 204.5
[M+H-H2O]+ 441.20389 193.5
[M+HCOO]- 503.20483 217.5
[M+CH3COO]- 517.22048 211.9
[M+Na-2H]- 479.18130 199.8
[M]+ 458.20608 203.6
[M]- 458.20718 203.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.